Crédit Industriel et Commercial’s Roivant Sciences ROIV Stock Holding History

Crédit Industriel et Commercial’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-150,000	Closed	-$3.25M	–	428
2025 Q4	$3.25M	Sell	150,000 -5,000	-3%	-$98.6K	0.25%	99
2025 Q3	$2.35M	Hold	155,000	–	–	0.2%	119
2025 Q2	$1.75M	Buy	155,000 +5,000	+3%	+$54.2K	0.15%	153
2025 Q1	$1.51M	Hold	150,000	–	–	0.16%	160
2024 Q4	$1.77M	Buy	+150,000	New	+$1.77M	0.23%	117

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Crédit Industriel et Commercial's ROIV Position: Q1 2026 in Review

Crédit Industriel et Commercial sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 150,000 shares — an estimated $3.25M sold.

Crédit Industriel et Commercial first reported a position in ROIV in Q4 2024 and held it in 5 quarters. The position peaked at $3.25M in Q4 2025. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Crédit Industriel et Commercial reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
Crédit Industriel et Commercial sold 150,000 Roivant Sciences shares in Q1 2026, an estimated $3.25M.
Crédit Industriel et Commercial first reported a position in Roivant Sciences in Q4 2024 and held it in 5 quarters.
Crédit Industriel et Commercial's Roivant Sciences position peaked at $3.25M in Q4 2025.
444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q1 2026, filed 29 Apr 2026.